Tue, Aug 20 10:20am

Compare GLMD

Big Percentage Losers (1)

Galmed Pharmaceuticals Ltd [GLMD]
$5.61 0.33 (5.56%)

GLMD Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 120 Million
GLMD Description

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Visit Website

GLMD Earnings

EPS -0.20 P/E Ratio 0.00
Previous Earnings Tue, May 7, 2019
Latest Earnings Mon, Aug 5, 2019 (15 days ago) +4.76%

GLMD Dividend

Yield --
Ex-Date --
Pay Date --
History --

GLMD Charts

1 Year
Aug 7, 2019
Oct 2, 2018

Symbol Price Day % YTD %
GLMD $5.61 -5.56% -26.18%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy